| Ytd | -42.05% | |
| 1y | -34.35% |
| Open | 4.76 | Prev Close | 4.66 | Low | 4.64 | High | 4.83 | Mkt Cap | 177.79M |
| Vol | 52.99K | Avg Vol | 194.10K | EPS | -1.07 | P/E | -4.43 | Forward P/E | -9.90 |
| Beta | 1.08 | Short Ratio | 11.20 | Inst. Own | 69.84% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 5.01 | 200-d Avg | 6.18 | 1yr Est | 8.00 |
LFCR News
Lifecore Biomedical, Inc. (LFCR) Q2 2026 Earnings Call Transcript
Lifecore Biomedical (NASDAQ:LFCR) reported quarterly losses of $(0.19) per share which beat the anal
Lifecore Biomedical (NASDAQ:LFCR) affirms FY2026 sales outlook from $120.000 million-$125.000 millio
-- Reaffirms 2026 Guidance -- -- Multiple New Business Wins, Adding Impactful Programs to Pipeline -
CHASKA, Minn., July 29, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifecor
--Technology Transfer Agreement for Regenerative Medicine Late-Stage Development Program-- --Two Add
CHASKA, Minn. , July 15, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecor
--Agreement Supports Tech Transfer and Commercial Manufacturing of Currently Marketed Neurology Prod
-- Agreement Calls for Tech Transfer in Preparation for Potential Commercial Manufacturing of Inject
CHASKA, Minn. , May 21, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore
CHASKA, Minn., May 12, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifecor
Lifecore Biomedical, Inc. (LFCR) Q1 2026 Earnings Call Transcript
-- Reaffirms 2026 Guidance -- -- Signed Three New Commercial Site Transfer Programs in First Quarter
CHASKA, Minn., April 29, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifec
CHASKA, Minn., April 22, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecor
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR - Get Free Report) have received a consensus recom
CHASKA, Minn., April 08, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecor
SAINT PAUL, Minn., April 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP and The Rosen Law Firm, P.A. ann
Kezar Life Sciences (NASDAQ: KZR - Get Free Report) and Lifecore Biomedical (NASDAQ: LFCR - Get Free
CHASKA, Minn., March 26, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecor
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after t
Gainers
On Friday, 497 companies set new 52-week lows.
During Friday's trading, 293 companies set new 52-week lows.
On Thursday, 241 companies hit new 52-week lows.